Low incidence of infectious complications after nonmyeloablative compared with myeloablative allogeneic stem cell transplantation
- 1 December 2004
- journal article
- Published by Wiley in Transplant Infectious Disease
- Vol. 6 (4) , 171-178
- https://doi.org/10.1111/j.1399-3062.2004.00075.x
Abstract
Allogeneic stem cell transplantation (SCT) using a myeloablative (MA) conditioning regimen is limited to relatively young patients because of increased transplant‐related mortality in elderly patients. Nonmyeloablative (NMA) conditioning regimens have been developed aiming to reduce transplant mortality. In this study, we set out to evaluate the post‐transplant occurrence of infectious complications in recipients of grafts from human leukocyte antigen (HLA)‐identical sibling donors treated with either NMA or MA conditioning regimens. Data of 78 consecutively treated patients were analyzed. An NMA conditioning regimen was used in 40 patients and an MA regimen in 38 patients. A significantly lower rate of episodes of febrile neutropenia (0% vs. 34%, PP<0.05) was found in SCT recipients treated with an NMA conditioning regimen compared with an MA conditioning regimen. Furthermore, fewer invasive fungal infections (2% vs. 12%, not significant) were diagnosed in the NMA group. The incidence of cytomegalovirus (CMV) reactivations and bacterial infections was low in both groups (CMV reactivations: 13% in both groups; bacterial infections: 10% in the NMA group vs. 8% in the MA group), while CMV disease developed in only 1 patient. Overall, compared to our MA regimen, we found a very low rate of infectious complications after NMA SCT.Keywords
This publication has 28 references indexed in Scilit:
- Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantationTransplantation and Cellular Therapy, 2004
- Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimenLeukemia, 2003
- Hematopoietic stem cell transplantation for hematological malignancies in EuropeLeukemia, 2003
- High Rate of Invasive Fungal Infections Following Nonmyeloablative Allogeneic TransplantationClinical Infectious Diseases, 2003
- High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantationBone Marrow Transplantation, 2002
- Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulinBone Marrow Transplantation, 2002
- CMV reactivation in nonmyeloablative HSCTBone Marrow Transplantation, 2001
- High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantationBone Marrow Transplantation, 2000
- Quantitative lymphocyte subset reconstitution after allogeneic hematopoietic transplantation from matched related donors with CD34+ selected PBPC grafts, unselected PBPC grafts or BM graftsBone Marrow Transplantation, 1999
- A Risk-Adapted Approach with a Short Course of Ganciclovir to Prevent Cytomegalovirus (CMV) Pneumonia in CMV-Seropositive Recipients of Allogeneic Bone Marrow TransplantsClinical Infectious Diseases, 1997